Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04733768
What this trial is testing

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alberta 100
Early research (Phase 1)Ended earlyNCT00313534
What this trial is testing

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Early research (Phase 1)Study completedNCT00779168
What this trial is testing

White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy

Who this might be right for
Prostate Cancer
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT04050215
What this trial is testing

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
Jonsson Comprehensive Cancer Center 937
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686380
What this trial is testing

IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

Who this might be right for
Recurrent Prostate CancerProstate Cancer
National Cancer Institute (NCI) 65
Early research (Phase 1)Study completedNCT04978675
What this trial is testing

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaProstate Adenocarcinoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT03513211
What this trial is testing

Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
St Vincent's Hospital, Sydney 12
Testing effectiveness (Phase 2)Ended earlyNCT04336943
What this trial is testing

Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
University of Washington 6
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Early research (Phase 1)Study completedNCT04216134
What this trial is testing

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate Carcinoma
City of Hope Medical Center 19
Not applicableEnded earlyNCT05437679
What this trial is testing

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Who this might be right for
High Risk Prostate CarcinomaBiochemically Recurrent Prostate CarcinomaCastration-resistant Prostate Cancer+1 more
Angle plc 9
Early research (Phase 1)Active Not RecruitingNCT06555796
What this trial is testing

Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer

Who this might be right for
Prostate CancerHigh-risk Biochemical RecurrenceHigh Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer+1 more
Amgen 50
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Early research (Phase 1)Active Not RecruitingNCT05077098
What this trial is testing

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
Mark Stein 8
Large-scale testing (Phase 3)Study completedNCT01272050
What this trial is testing

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 350
Large-scale testing (Phase 3)Looking for participantsNCT07831824
What this trial is testing

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 408
Large-scale testing (Phase 3)Ended earlyNCT05744115
What this trial is testing

Ga-68-PSMA-11 in Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Timothy Hoffman 38
Testing effectiveness (Phase 2)Looking for participantsNCT06220188
What this trial is testing

PSMA-RLT in Biochemically Recurrent PCa

Who this might be right for
Prostate Cancer Recurrent
Medical University of Vienna 20
Next Page